Eric Rhodes
Plus aucun poste en cours
Profil
Eric Rhodes served as the Chief Executive Officer at ERS Genomics Ltd.
from 2016 to 2024.
Prior to that, he worked as the Director of Business Development at Sigma-Aldrich Corp.
and as the VP of Business Development & Alliance Management at Sangamo Therapeutics, Inc. He also held the position of CTO and Vice President of Research & Development at Horizon Discovery Ltd.
and CTO and Senior Vice President of R&D at Horizon Discovery Group Ltd.
Mr. Rhodes completed his undergraduate degree at the University of California, Berkeley.
Anciens postes connus de Eric Rhodes
| Sociétés | Poste | Fin |
|---|---|---|
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Directeur Général | 13/05/2024 |
| HORIZON DISCOVERY GROUP PLC | Directeur Technique/Scientifique/R&D | 01/05/2016 |
| SIGMA-ALDRICH CORPORATION | Corporate Officer/Principal | - |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Formation de Eric Rhodes
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Sigma-Aldrich Corp.
 Sigma-Aldrich Corp. Wholesale DistributorsDistribution Services Sigma-Aldrich Corp. operates as a life science and technology material company. It develops, manufactures, purchases and distributes a broad range of biochemical and organic chemicals. Its services include basic research, product and process development, manufacturing and production, regulatory compliance, and facility operations. was founded in May 1975 and is headquartered in St. Louis, MO. | Distribution Services |
Horizon Discovery Group Ltd.
 Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Health Technology |